<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="./PMC5493079/results/search/sars_covid_2/results.xml">
  <result pre="Santos P081 - Clinical features and outcomes of patients with" exact="Middle East respiratory syndrome" post="requiring admission to a saudi intensive care unit: A"/>
  <result pre="P082 - The ICU response to a hospital outbreak of" exact="Middle East respiratory syndrome" post="coronavirus infection H. Al-Dorzi, R. Khan, S. Baharoon, A."/>
  <result pre="with MEDI3902, a Novel Bispecific Monoclonal Antibody, against P aeruginosa" exact="virulence factors" post="J. Chastre, B. François, A. Torres, C. E. Luyt,"/>
  <result pre="patients K. Kogelmann, M. Drüner, D. Jarczak P196 - Oxiris" exact="membrane" post="decreases endotoxin during rrt in septic patients with basal"/>
  <result pre="P. Morgan P260 - Sedation and analgesia practice in extra-corporeal" exact="membrane" post="oxygenation (ECMO)-treated patients with acute respiratory distress syndrome (ARDS):"/>
  <result pre="of patients deemed not eligible when referred for veno-venous extracorporeal" exact="membrane" post="oxygenation (vv-ECMO) S. Poo, K. Mahendran, J. Fowles, C."/>
  <result pre="Jovinge P264 - Lung function six months post extra corporeal" exact="membrane" post="oxygenation (ECMO) for severe acute respiratory failure in adult"/>
  <result pre="flu. References 1. Gordon C. et al. Association between severe" exact="pandemic" post="2009 influenza A (H1N1) virus infection and immunoglobulin G(2)"/>
  <result pre="G2 level in severe cases than in mild cases of" exact="pandemic" post="H1N1 2009 influenza is associated with cytokine dysregulation. Clin"/>
  <result pre="appropriate RT-qPCR designs: one specific of the variant encoding the" exact="membrane" post="form of IL-7R, one specific of a variant corresponding"/>
  <result pre="the transcription variant used, in particular at D3 for the" exact="membrane" post="form and for the potential soluble form of IL7R"/>
  <result pre="derived from five blood-cell derived parameters that characterize the innate" exact="immune response" post="in routine blood samples, the intensive care infection score"/>
  <result pre="the ICU. P081 Clinical features and outcomes of patients with" exact="Middle East respiratory syndrome" post="requiring admission to a saudi intensive care unit: A"/>
  <result pre="our 20-bed mixed medico-surgical ICU who were diagnosed with confirmed" exact="MERS-CoV" post="between Oct 1, 2012 and May 31, 2014 were"/>
  <result pre="During the observation period, 31 patients were identified as having" exact="MERS-CoV" post="infection (mean age 59 ± 20 years, 71 % males). The"/>
  <result pre="was 3 (IQ: 2-4). The initial clinical manifestations of the" exact="MERS-CoV" post="infections had occurred at a median of 2 days"/>
  <result pre="p = 0.48) and vasopressor therapy (95.7 vs. 37.5 %, p = 0.002). Conclusions:" exact="MERS-CoV" post="infection requiring admission to the ICU is associated with"/>
  <result pre="therapy. P082 The ICU response to a hospital outbreak of" exact="Middle East respiratory syndrome" post="coronavirus infection H. Al-Dorzi, R. Khan, S. Baharoon, A."/>
  <result pre="the response of our intensive care unit (ICU) to a" exact="MERS-CoV" post="hospital outbreak. Methods: This observational study was conducted at"/>
  <result pre="1000-bed tertiary-care hospital in Riyadh, Saudi Arabia which had a" exact="MERS-CoV" post="outbreak in Aug-Sep 2015. Our Intensive Care Department covered"/>
  <result pre="4 needed continuous renal replacement therapy and one had extracorporeal" exact="membrane" post="oxygenation. The hospital mortality of ICU MERS patients was"/>
  <result pre="and 30 days for physicians. Conclusions: Our hospital outbreak of" exact="MERS-CoV" post="resulted in many patients requiring organ support and prolonged"/>
  <result pre="attempt to analyze all publically available global surveillance data of" exact="MERS-CoV" post="cases reported by the WHO to date. Methods: We"/>
  <result pre="to date. Methods: We analyzed all outbreak news archives of" exact="MERS-CoV" post="between September 23, 2012 and October 1, 2015(1). We"/>
  <result pre="healthcare worker, contact with camels, contact with a laboratory confirmed" exact="MERS-CoV" post="case, date of symptom onset and date of laboratory"/>
  <result pre="with MEDI3902, a Novel Bispecific Monoclonal Antibody, against P aeruginosa" exact="virulence factors" post="J. Chastre 1, B. François 2, A. Torres 3,"/>
  <result pre="array of factors that contribute to its virulence. Two such" exact="virulence factors" post="are the Psl exopolysaccharide, which contributes to bacterial persistence,"/>
  <result pre="epithelial type II A549 cells were cultured on an elastic" exact="membrane" post="and incubated with cells or supernatant from stored (35-42"/>
  <result pre="recirculation system. PAMPS cause either direct damage or trigger an" exact="immune response" post="in the host to fight infection leading to the"/>
  <result pre="means, in addition to cytokine reduction, of reducing the uncontrolled" exact="immune response" post="that contributes to a maladaptive SIRS response, organ injury"/>
  <result pre="and septic shock. Intensive Care Med (2004) 30:536–555 P196 Oxiris" exact="membrane" post="decreases endotoxin during rrt in septic patients with basal"/>
  <result pre="studies evaluate whether Renal Replacement Therapy (RRT) with an adsorbing" exact="membrane" post="may decrease endotoxin and modulate pro inflammatory mediators [1]."/>
  <result pre="sepsis / septic shock submitted to RRT with an adsorbing" exact="membrane" post="(oXiris , Gambro) were stratified in three groups according"/>
  <result pre="(EAA 0,5 ± 0,2 vs .0,66 ± 0,13 . p &amp;lt; 0,01). Conclusions: 1 The adsorbing" exact="membrane" post="oXiris may decrease endotoxin in patients with EAA &amp;gt; 0,6. -2"/>
  <result pre="2143 5722 7865 P260 Sedation and analgesia practice in extra-corporeal" exact="membrane" post="oxygenation (ECMO)-treated patients with acute respiratory distress syndrome (ARDS):"/>
  <result pre="of patients deemed not eligible when referred for veno-venous extracorporeal" exact="membrane" post="oxygenation (vv-ECMO) S. Poo 1, K. Mahendran 2, J."/>
  <result pre="Institute, Grand Rapids, USA Introductions: Patient selection for veno-arterial extracorporeal" exact="membrane" post="oxygenation (VA-ECMO) in refractory cardiogenic shock, in particular the"/>
  <result pre="confidence intervals P264 Lung function six months post extra corporeal" exact="membrane" post="oxygenation (ECMO) for severe acute respiratory failure in adult"/>
  <result pre="injury and multiple trauma occurred in 20 % (n = 9/46). The" exact="case fatality rate" post="was 2 % (n = 1/46). Conclusions Majority of burns are"/>
  <result pre="Heard ML, Labuz MD et al. Hair loss after extracorporeal" exact="membrane" post="oxygenation. Pediatr Crit Care Med 2003;4:363-366. P405 The impact"/>
 </snippets>
</snippetsTree>
